Tag: #PrenatalTesting

Introduction Prenatal diagnosis is undergoing a rapid transformation, and new research offers a potential game-changer: measuring ischemia-modified albumin (IMA) in amniotic fluid to diagnose Down Syndrome with 95% sensitivity—within just an hour. This breakthrough could significantly reduce the emotional burden faced by expecting parents during the long wait for diagnostic results. Visit https://www.obstetricgynecoljournal.com for more…